Work

Benzyl- and phenyl-disubstituted 1,2,4-oxadiazoles as potent and selective monoamine oxidase B inhibitors: synthesis, SAR and molecular docking studies

Year: 2026
Type: preprint
Abstract: A series of novel 1,2,4-oxadiazole derivatives substituted with both the benzyl and phenyl moieties were investigated as potential selective monoamine oxidase B (MAO-B) inhibitors. The target compounds were synthesized in a two-step, one-pot protocol from arylacetic acids and amidoximes via O-acylamidoxime intermediates, followed by base-catalyzed cyclization; the products were obtained in 65–95% yields without chromatographic purification. All final compounds were fully characterized by ¹H and ¹³C NMR spectroscopy and HRMS, and their purity was confirmed by HPLC-UV (≥ 95%). The synthesized derivatives were evaluated for their inhibitory activity against human MAO-A and MAO-B. The most active compound, [3-(4-fluorophenyl)-5-(4-methylbenzyl)-1,2,4-oxadiazole], exhibited an IC₅₀ of 0.085 µM against MAO-B with no detectable inhibition of MAO-A at the highest concentration tested (100 µM), thus demonstrating pronounced isoform selectivity. Structure-activity relationship (SAR) analysis revealed that substitution with the benzyl and phenyl on either positions C3 or C5 yielded potent MAO-B inhibitors. It was concluded that the elongated structure of the derivatives was responsible for selective MAO-B inhibition. These results identify disubstitution of 1,2,4-oxadiazole with benzyl and phenyl moieties as a promising strategy for the rational design of potent and selective MAO-B inhibitors, with representing a valuable lead for further optimization.
Language: English
Field: Chemistry
Open Access status: green
OpenAlex ID: W7235909610
Cites: 39
Cited by:
Related to: 10